Based on new information, complete directions for use including risk statements are required on the labels of some products containing 40mg/dosage unit or more of glucomannan to mitigate throat, esophageal or intestinal obstruction following ingestion of these products.
Depth of distribution
Shipped to wholesaler. Wholesaler shipped the products directly to the consumers.